Besides fewer infiltrations of CD8+ T cells in the TME, the expression level of PD-1 molecules on CD8+ T cells was relatively lower in the later-stage GC patients in comparison with early-stage GC patients (Figure 4D). The gene discussed is PDCD1; the disease is gastric cancer.